Cargando…

Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes

Detalles Bibliográficos
Autores principales: Yap, Timothy A., Hamilton, Erika, Bauer, Todd, Dumbrava, Ecaterina E., Jeselsohn, Rinath, Enke, Aaron, Hurley, Sabrina, Lin, Kevin K., Habeck, Jenn, Giordano, Heidi, Shapiro, Geoffrey I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865521/
https://www.ncbi.nlm.nih.gov/pubmed/35138920
http://dx.doi.org/10.1200/PO.21.00456
_version_ 1784655650118172672
author Yap, Timothy A.
Hamilton, Erika
Bauer, Todd
Dumbrava, Ecaterina E.
Jeselsohn, Rinath
Enke, Aaron
Hurley, Sabrina
Lin, Kevin K.
Habeck, Jenn
Giordano, Heidi
Shapiro, Geoffrey I.
author_facet Yap, Timothy A.
Hamilton, Erika
Bauer, Todd
Dumbrava, Ecaterina E.
Jeselsohn, Rinath
Enke, Aaron
Hurley, Sabrina
Lin, Kevin K.
Habeck, Jenn
Giordano, Heidi
Shapiro, Geoffrey I.
author_sort Yap, Timothy A.
collection PubMed
description
format Online
Article
Text
id pubmed-8865521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-88655212022-02-24 Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes Yap, Timothy A. Hamilton, Erika Bauer, Todd Dumbrava, Ecaterina E. Jeselsohn, Rinath Enke, Aaron Hurley, Sabrina Lin, Kevin K. Habeck, Jenn Giordano, Heidi Shapiro, Geoffrey I. JCO Precis Oncol Case Reports Wolters Kluwer Health 2022-02-09 /pmc/articles/PMC8865521/ /pubmed/35138920 http://dx.doi.org/10.1200/PO.21.00456 Text en © 2022 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Case Reports
Yap, Timothy A.
Hamilton, Erika
Bauer, Todd
Dumbrava, Ecaterina E.
Jeselsohn, Rinath
Enke, Aaron
Hurley, Sabrina
Lin, Kevin K.
Habeck, Jenn
Giordano, Heidi
Shapiro, Geoffrey I.
Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes
title Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes
title_full Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes
title_fullStr Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes
title_full_unstemmed Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes
title_short Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes
title_sort phase ib seastar study: combining rucaparib and sacituzumab govitecan in patients with cancer with or without mutations in homologous recombination repair genes
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865521/
https://www.ncbi.nlm.nih.gov/pubmed/35138920
http://dx.doi.org/10.1200/PO.21.00456
work_keys_str_mv AT yaptimothya phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT hamiltonerika phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT bauertodd phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT dumbravaecaterinae phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT jeselsohnrinath phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT enkeaaron phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT hurleysabrina phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT linkevink phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT habeckjenn phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT giordanoheidi phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes
AT shapirogeoffreyi phaseibseastarstudycombiningrucaparibandsacituzumabgovitecaninpatientswithcancerwithorwithoutmutationsinhomologousrecombinationrepairgenes